166 related articles for article (PubMed ID: 24750239)
41. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
[TBL] [Abstract][Full Text] [Related]
42. Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis C.
Bräu N
J Viral Hepat; 2004 May; 11(3):191-7. PubMed ID: 15117320
[TBL] [Abstract][Full Text] [Related]
43. Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin.
Snoeck E; Wade JR; Duff F; Lamb M; Jorga K
Br J Clin Pharmacol; 2006 Dec; 62(6):699-709. PubMed ID: 17118125
[TBL] [Abstract][Full Text] [Related]
44. Predictors of changes in hemoglobin levels in patients with chronic hepatitis C treated with ribavirin plus pegylated interferon-α.
Hu CC; Weng CH; Lin CL; Tien HC; Kuo YL; Chien CH; Yen CL; Lin CY; Chien RN
Ren Fail; 2012; 34(4):429-34. PubMed ID: 22264026
[TBL] [Abstract][Full Text] [Related]
45. Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study.
Pontali E; Angeli E; Cattelan AM; Maida I; Nasta P; Verucchi G; Caputo A; Iannacone C; Puoti M
Antivir Ther; 2015; 20(1):39-48. PubMed ID: 24831457
[TBL] [Abstract][Full Text] [Related]
46. Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?
Gluhovschi C; Gadalean F; Kaycsa A; Curescu M; Sporea I; Gluhovschi G; Petrica L; Velciov S; Bozdog G; Bob F; Vernic C; Cioca D
Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):744-50. PubMed ID: 21320001
[TBL] [Abstract][Full Text] [Related]
47. Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
Núñez M; Miralles C; Berdún MA; Losada E; Aguirrebengoa K; Ocampo A; Arazo P; Cervantes M; de Los Santos I; San Joaquín I; Echeverría S; Galindo MJ; Asensi V; Barreiro P; Sola J; Hernandez-Burruezo JJ; Guardiola JM; Romero M; García-Samaniego J; Soriano V;
AIDS Res Hum Retroviruses; 2007 Aug; 23(8):972-82. PubMed ID: 17725413
[TBL] [Abstract][Full Text] [Related]
48. Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients.
Gane EJ; Rouzier R; Stedman C; Wiercinska-Drapalo A; Horban A; Chang L; Zhang Y; Sampeur P; Nájera I; Smith P; Shulman NS; Tran JQ
J Hepatol; 2011 Nov; 55(5):972-9. PubMed ID: 21354234
[TBL] [Abstract][Full Text] [Related]
49. Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients.
Nishimura T; Osaki R; Shioya M; Imaeda H; Aomatsu T; Takeuchi T; Okumura Y; Fujiyama Y; Andoh A
Mol Med Rep; 2012 Feb; 5(2):517-20. PubMed ID: 22052220
[TBL] [Abstract][Full Text] [Related]
50. Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.
Posthouwer D; Fischer K; De Heusden N; Mauser-Bunschoten EP
Haemophilia; 2007 Jan; 13(1):98-103. PubMed ID: 17212733
[TBL] [Abstract][Full Text] [Related]
51. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
[TBL] [Abstract][Full Text] [Related]
52. AIDS-related Kaposi's sarcoma can occur during peginterferon-α and ribavirin therapy for chronic hepatitis C infection.
de Lastours V; Pavie J; Delaugerre C; Molina JM
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(1):9-11. PubMed ID: 21934116
[TBL] [Abstract][Full Text] [Related]
53. Anti-Viral Therapy and Decreased Sexual Desire in Patients with Chronic Hepatitis C.
Hsiao PJ; Hsieh PF; Chou EC; Lai HC; Peng CY; Su KP
PLoS One; 2016; 11(8):e0160450. PubMed ID: 27505293
[TBL] [Abstract][Full Text] [Related]
54. Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients.
Ahmed WH; Furusyo N; Zaky S; Eldin AS; Aboalam H; Ogawa E; Murata M; Hayashi J
World J Gastroenterol; 2013 Mar; 19(9):1387-95. PubMed ID: 23538996
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
Emery JS; Kuczynski M; La D; Almarzooqi S; Kowgier M; Shah H; Wong D; Janssen HLA; Feld JJ
Am J Gastroenterol; 2017 Aug; 112(8):1298-1308. PubMed ID: 28291241
[TBL] [Abstract][Full Text] [Related]
56. Pegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personality.
Castellvi P; Navinés R; Gutierrez F; Jiménez D; Márquez C; Subirà S; Solà R; Martín-Santos R
J Clin Psychiatry; 2009 Jun; 70(6):817-28. PubMed ID: 19573480
[TBL] [Abstract][Full Text] [Related]
57. [Autoimmune hepatitis and membranous glomerulonephritis under immune therapy in chronic hepatitis C].
Paparoupa M; Huy Ho NA; Schuppert F
Dtsch Med Wochenschr; 2016 May; 141(10):709-11. PubMed ID: 27176065
[TBL] [Abstract][Full Text] [Related]
58. IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS.
Dresch KF; Mattos AA; Tovo CV; Onofrio FQ; Casagrande L; Feltrin AA; Barros IC; Almeida PR
Rev Inst Med Trop Sao Paulo; 2016; 58():37. PubMed ID: 27253739
[TBL] [Abstract][Full Text] [Related]
59. Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study.
Hayashi N; George J; Shiroeda H; Saito T; Toshikuni N; Tsuchishima M; Arisawa T; Tsutsumi M
J Gastroenterol Hepatol; 2013 Jun; 28(6):1015-8. PubMed ID: 23425065
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of pegylated interferon in children and adolescents infected with chronic hepatitis C: a preliminary study.
Abdel-Aziz DH; Sabry NA; El-Sayed MH; El-Gazayerly ON
J Pharm Pract; 2011 Apr; 24(2):203-10. PubMed ID: 21712215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
